A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas (clinicaltrials.gov) - Sep 25, 2026 - P1 | N=14 | Terminated | Sponsor: Boehringer Ingelheim | N=135 ➔ 14 | Active, not recruiting ➔ Terminated; Sponsor decision
Enrollment change • Trial termination • Colon Cancer • Colorectal Cancer • Gastric Cancer • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Rectal Cancer • Solid Tumor
|